TY - JOUR
T1 - Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma
AU - Weis, Sebastian
AU - Franke, Annegret
AU - Mössner, Joachim
AU - Jakobsen, Janus C
AU - Schoppmeyer, Konrad
PY - 2013
Y1 - 2013
N2 - Hepatocellular carcinoma is the fifth most common cancer worldwide. Percutaneous interventional therapies, such as radiofrequency (thermal) ablation (RFA), have been developed for early hepatocellular carcinoma. RFA competes with other interventional techniques such as percutaneous ethanol injection, surgical resection, and liver transplantation. The potential benefits and harms of RFA compared with placebo, no intervention, chemotherapy, hepatic resection, liver transplantation, or other interventions are unclear.
AB - Hepatocellular carcinoma is the fifth most common cancer worldwide. Percutaneous interventional therapies, such as radiofrequency (thermal) ablation (RFA), have been developed for early hepatocellular carcinoma. RFA competes with other interventional techniques such as percutaneous ethanol injection, surgical resection, and liver transplantation. The potential benefits and harms of RFA compared with placebo, no intervention, chemotherapy, hepatic resection, liver transplantation, or other interventions are unclear.
U2 - 10.1002/14651858.CD003046.pub3
DO - 10.1002/14651858.CD003046.pub3
M3 - Journal article
C2 - 24357457
SN - 1469-493X
VL - 12
SP - CD003046
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
ER -